PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsSertraline
Sertraline
Sertraline, Zoloft (sertraline) is a small molecule pharmaceutical. Sertraline was first approved as Zoloft on 1991-12-30. It is used to treat depressive disorder, feeding and eating disorders, obsessive-compulsive disorder, panic disorder, and post-traumatic stress disorders in the USA. The pharmaceutical is active against sodium-dependent serotonin transporter.
Download report
Favorite
Top Prescription Drugs
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
mental disordersD001523
Trade Name
FDA
EMA
Sertraline, Zoloft (discontinued: Sertraline, Zoloft)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sertraline hydrochloride
Tradename
Company
Number
Date
Products
SERTRALINE HYDROCHLORIDEAlmatica PharmaN-215133 RX2021-10-04
2 products, RLD
ZOLOFTViatrisN-019839 RX1991-12-30
3 products, RLD, RS
ZOLOFTViatrisN-020990 RX1999-12-07
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
sertralineANDA2025-10-03
sertraline hclANDA2024-05-16
sertraline hydrochlorideANDA2025-11-17
sertraline hydrochloride tabletsANDA2009-08-20
zoloftNew Drug Application2023-08-15
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
panic disorderEFO_0004262D016584F41.0
post-traumatic stress disordersEFO_0001358D013313F43.1
obsessive-compulsive disorderEFO_0004242D009771F42
depressive disorderEFO_1002014D003866F32.A
feeding and eating disorders—D001068F50
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
— N06: Psychoanaleptics
— N06A: Antidepressants
— N06AB: Selective serotonin reuptake inhibitors
— N06AB06: Sertraline
HCPCS
No data
Clinical
Clinical Trials
427 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DepressionD003863—F33.9938376072206
Depressive disorderD003866EFO_1002014F32.A1033374655172
Major depressive disorderD003865EFO_0003761F22822253137120
Post-traumatic stress disordersD013313EFO_0001358F43.145813836
Anxiety disordersD001008EFO_0006788F41.118691334
Traumatic stress disordersD040921——34710527
Obsessive-compulsive disorderD009771EFO_0004242F42—238921
Compulsive personality disorderD003193—F60.5—237718
Healthy volunteers/patients———14——2218
Treatment-resistant depressive disorderD061218——1174114
Show 53 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cognitive dysfunctionD060825—G31.84——1—56
SchizophreniaD012559EFO_0000692F20——2—35
Heart failureD006333EFO_0003144I50—11—34
Sleep initiation and maintenance disordersD007319—F51.01—13—14
Separation anxietyD001010EFO_1001916——11—24
Cardiovascular diseasesD002318EFO_0000319I98—11—24
Autistic disorderD001321EFO_0003758F84.0—31——4
Wounds and injuriesD014947—T14.8111—24
Heart diseasesD006331EFO_0003777I51.9112——4
Brain injuriesD001930—S06.9—11—23
Show 29 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Substance-related disordersD019966EFO_0003890F13—2——24
Autism spectrum disorderD000067877—F84.0—3———3
Pervasive child development disordersD002659EFO_0003756F84—2———2
Parkinson diseaseD010300EFO_0002508G2011——12
Hepatitis cD006526—B19.211———2
Fragile x syndromeD005600—Q99.2—2———2
Cocaine-related disordersD019970—F14—2———2
PruritusD011537—L29—2———2
GlioblastomaD005909EFO_0000515—11———1
Postural orthostatic tachycardia syndromeD054972—G90.A11———1
Show 23 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OverweightD050177—E66.31———12
Huntington diseaseD006816Orphanet_399G101————1
LeukemiaD007938—C951————1
Myeloid leukemia acuteD015470—C92.01————1
Myeloid leukemiaD007951—C921————1
Myelodysplastic syndromesD009190—D461————1
PreleukemiaD011289——1————1
Migraine disordersD008881EFO_0003821G431————1
VertigoD014717—H81.391————1
DizzinessD004244—R421————1
Show 3 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Taste disordersD013651——————33
Psychological distressD000079225——————33
InflammationD007249MP_0001845—————22
Suicidal ideationD059020EFO_0004320R45.851————22
HypoglycemiaD007003—E16.2————22
MalnutritionD044342EFO_0008572E40-E46————22
Breast neoplasmsD001943EFO_0003869C50————22
Hot flashesD019584——————22
HemorrhageD006470MP_0001914R58————11
Covid-19D000086382—U07.1————11
Show 66 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSertraline
INNsertraline
Description
Sertraline is a member of the class of tetralins that is tetralin which is substituted at positions 1 and 4 by a methylamino and a 3,4-dichlorophenyl group, respectively (the S,S diastereoisomer). A selective serotonin-reuptake inhibitor (SSRI), it is administered orally as the hydrochloride salt as an antidepressant for the treatment of depression, obsessive-compulsive disorder, panic disorder and post-traumatic stress disorder. It has a role as an antidepressant and a serotonin uptake inhibitor. It is a member of tetralins, a secondary amino compound and a dichlorobenzene. It is a conjugate base of a sertraline(1+). It derives from a hydride of a tetralin.
Classification
Small molecule
Drug classselective serotonin reuptake inhibitors (SSRI)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21
Identifiers
PDB—
CAS-ID79617-96-2
RxCUI—
ChEMBL IDCHEMBL809
ChEBI ID9123
PubChem CID68617
DrugBankDB01104
UNII IDQUC7NX6WMB (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Zoloft – Viatris
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Zoloft – Pfizer
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Sertraline
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 26,692 documents
View more details
Safety
Black-box Warning
Black-box warning for: Sertraline, Sertraline hcl, Sertraline hydrochloride, Sertraline hydrochloride tablets, Zoloft
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
72,100 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use